Report Detail

Pharma & Healthcare Global Pimozide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2930177
  • |
  • 12 February, 2019
  • |
  • Global
  • |
  • 124 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Scope of the Report:
The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Pimozide includes 1Mg, 2Mg, 4Mg, and the proportion of 2Mg in 2017 is about 53%.
Pimozide is widely used in hospitals, drugstores and other places. The most proportion of Pimozide is used for hospitals in 2017 is 54%.
The worldwide market for Pimozide is expected to grow at a CAGR of roughly -1.1% over the next five years, will reach 11 million US$ in 2024, from 12 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pimozide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
1Mg
2Mg
4Mg

Market Segment by Applications, can be divided into
Hospitals
Drugstores
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pimozide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pimozide, with price, sales, revenue and global market share of Pimozide in 2017 and 2018.
Chapter 3, the Pimozide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pimozide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pimozide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pimozide sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Pimozide Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 1Mg
      • 1.2.2 2Mg
      • 1.2.3 4Mg
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospitals
      • 1.3.2 Drugstores
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Teva
      • 2.1.1 Business Overview
      • 2.1.2 Pimozide Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Teva Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Par Pharmaceutical
      • 2.2.1 Business Overview
      • 2.2.2 Pimozide Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Par Pharmaceutical Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Johnson & Johnson
      • 2.3.1 Business Overview
      • 2.3.2 Pimozide Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Johnson & Johnson Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Eumedica
      • 2.4.1 Business Overview
      • 2.4.2 Pimozide Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Eumedica Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Pharmascience
      • 2.5.1 Business Overview
      • 2.5.2 Pimozide Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Pharmascience Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Domina Pharmaceuticals
      • 2.6.1 Business Overview
      • 2.6.2 Pimozide Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Domina Pharmaceuticals Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Aa Pharma
      • 2.7.1 Business Overview
      • 2.7.2 Pimozide Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Aa Pharma Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Pimozide Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Pimozide Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Pimozide Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Pimozide Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Pimozide Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Pimozide Market Analysis by Regions

    • 4.1 Global Pimozide Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Pimozide Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Pimozide Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Pimozide Sales and Growth Rate (2014-2019)
    • 4.3 Europe Pimozide Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Pimozide Sales and Growth Rate (2014-2019)
    • 4.5 South America Pimozide Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Pimozide Sales and Growth Rate (2014-2019)

    5 North America Pimozide by Country

    • 5.1 North America Pimozide Sales, Revenue and Market Share by Country
      • 5.1.1 North America Pimozide Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Pimozide Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Pimozide Sales and Growth Rate (2014-2019)
    • 5.3 Canada Pimozide Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Pimozide Sales and Growth Rate (2014-2019)

    6 Europe Pimozide by Country

    • 6.1 Europe Pimozide Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Pimozide Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Pimozide Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Pimozide Sales and Growth Rate (2014-2019)
    • 6.3 UK Pimozide Sales and Growth Rate (2014-2019)
    • 6.4 France Pimozide Sales and Growth Rate (2014-2019)
    • 6.5 Russia Pimozide Sales and Growth Rate (2014-2019)
    • 6.6 Italy Pimozide Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Pimozide by Country

    • 7.1 Asia-Pacific Pimozide Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Pimozide Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Pimozide Revenue and Market Share by Country (2014-2019)
    • 7.2 China Pimozide Sales and Growth Rate (2014-2019)
    • 7.3 Japan Pimozide Sales and Growth Rate (2014-2019)
    • 7.4 Korea Pimozide Sales and Growth Rate (2014-2019)
    • 7.5 India Pimozide Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Pimozide Sales and Growth Rate (2014-2019)

    8 South America Pimozide by Country

    • 8.1 South America Pimozide Sales, Revenue and Market Share by Country
      • 8.1.1 South America Pimozide Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Pimozide Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Pimozide Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Pimozide Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Pimozide Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Pimozide by Countries

    • 9.1 Middle East and Africa Pimozide Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Pimozide Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Pimozide Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Pimozide Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Pimozide Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Pimozide Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Pimozide Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Pimozide Sales and Growth Rate (2014-2019)

    10 Global Pimozide Market Segment by Type

    • 10.1 Global Pimozide Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Pimozide Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Pimozide Revenue and Market Share by Type (2014-2019)
    • 10.2 1Mg Sales Growth and Price
      • 10.2.1 Global 1Mg Sales Growth (2014-2019)
      • 10.2.2 Global 1Mg Price (2014-2019)
    • 10.3 2Mg Sales Growth and Price
      • 10.3.1 Global 2Mg Sales Growth (2014-2019)
      • 10.3.2 Global 2Mg Price (2014-2019)
    • 10.4 4Mg Sales Growth and Price
      • 10.4.1 Global 4Mg Sales Growth (2014-2019)
      • 10.4.2 Global 4Mg Price (2014-2019)

    11 Global Pimozide Market Segment by Application

    • 11.1 Global Pimozide Sales Market Share by Application (2014-2019)
    • 11.2 Hospitals Sales Growth (2014-2019)
    • 11.3 Drugstores Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Pimozide Market Forecast (2019-2024)

    • 12.1 Global Pimozide Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Pimozide Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Pimozide Market Forecast (2019-2024)
      • 12.2.2 Europe Pimozide Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Pimozide Market Forecast (2019-2024)
      • 12.2.4 South America Pimozide Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Pimozide Market Forecast (2019-2024)
    • 12.3 Pimozide Market Forecast by Type (2019-2024)
      • 12.3.1 Global Pimozide Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Pimozide Market Share Forecast by Type (2019-2024)
    • 12.4 Pimozide Market Forecast by Application (2019-2024)
      • 12.4.1 Global Pimozide Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Pimozide Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Pimozide . Industry analysis & Market Report on Pimozide is a syndicated market report, published as Global Pimozide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Pimozide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,690.04
      4,035.06
      5,380.08
      3,239.88
      4,859.82
      6,479.76
      531,361.20
      797,041.80
      1,062,722.40
      293,712.00
      440,568.00
      587,424.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report